United States — California State Board of Pharmacy
Tracked across 2 events · 12 articles · First seen Jun 27, 2026 · Last active Aug 23, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: The United States — California State Board of Pharmacy issued an alert regarding Amgen's recall of Corlanor and Sensipar tablets, providing details on the foreign matter and the precautionary measures taken.
Jun 27, 2026 · 6 articles
Domestic
Impact: Reversed regulations that would have restricted glutathione access, a decision now under scrutiny given safety concerns. May face pressure to re-evaluate.
Aug 23, 2026 · 6 articles
ERGEN INTELLIGENCE
Track United States — California State Board of Pharmacy live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard